- Home
- EVRI vs SEPN Comparison
EVRI vs SEPN Comparison
Compare EVRI & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVRI
- SEPN
- Stock Information
- Founded
- EVRI 1998
- SEPN 2022
- Country
- EVRI United States
- SEPN United States
- Employees
- EVRI N/A
- SEPN N/A
- Industry
- EVRI Services-Misc. Amusement & Recreation
- SEPN
- Sector
- EVRI Consumer Discretionary
- SEPN
- Exchange
- EVRI Nasdaq
- SEPN NYSE
- Market Cap
- EVRI 1.2B
- SEPN 1.0B
- IPO Year
- EVRI 2005
- SEPN 2024
- Fundamental
- Price
- EVRI $13.63
- SEPN $14.54
- Analyst Decision
- EVRI Hold
- SEPN Strong Buy
- Analyst Count
- EVRI 5
- SEPN 4
- Target Price
- EVRI $12.88
- SEPN $43.67
- AVG Volume (30 Days)
- EVRI 523.7K
- SEPN 212.8K
- Earning Date
- EVRI 02-27-2025
- SEPN 02-15-2025
- Dividend Yield
- EVRI N/A
- SEPN N/A
- EPS Growth
- EVRI N/A
- SEPN N/A
- EPS
- EVRI 0.15
- SEPN N/A
- Revenue
- EVRI $760,419,000.00
- SEPN $981,000.00
- Revenue This Year
- EVRI N/A
- SEPN $406.62
- Revenue Next Year
- EVRI $5.06
- SEPN N/A
- P/E Ratio
- EVRI $91.20
- SEPN N/A
- Revenue Growth
- EVRI N/A
- SEPN N/A
- 52 Week Low
- EVRI $6.37
- SEPN $13.97
- 52 Week High
- EVRI $13.65
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- EVRI 59.59
- SEPN N/A
- Support Level
- EVRI $13.59
- SEPN N/A
- Resistance Level
- EVRI $13.65
- SEPN N/A
- Average True Range (ATR)
- EVRI 0.04
- SEPN 0.00
- MACD
- EVRI -0.00
- SEPN 0.00
- Stochastic Oscillator
- EVRI 63.64
- SEPN 0.00
About EVRI Everi Holdings Inc.
Everi Holdings Inc provides entertainment and technology solutions for the casino, interactive, and gaming industry. It operates in two segments namely Games and Financial Technology Solutions (FinTech). Enveri Games provides gaming operators with gaming technology products and services which include gaming machines, slot machines, leased gaming equipment, and other products and services. Enveri FinTech provides gaming operators with financial technology products and services which include services and equipment that facilitate casino patron's to access cash at gaming facilities through automated teller machines, point of sale debit card purchases and others.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.